These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6533013)

  • 1. Experimental model for evaluating animal exposure to endogenous N-nitrosodi-n-butylamine by measuring its urinary metabolites N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-butyl-N-(3-carboxypropyl)nitrosamine.
    Airoldi L; Spagone C; Macri A; Fanelli R
    IARC Sci Publ; 1984; (57):237-40. PubMed ID: 6533013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites].
    Morishita S; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder.
    Suzuki E; Aoki J; Okada M
    Gan; 1981 Aug; 72(4):547-51. PubMed ID: 7308666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E; Anjo T; Aoki J; Okada M
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid assay of N-butyl-N-(3-carboxypropyl)nitrosamine in rat organs and urine by high-performance liquid chromatography after derivatization.
    Wada S; Funae Y; Imaoka S; Kawamura M; Kinoshita Y; Sugimoto T; Nishio S; Kishimoto T; Maekawa M
    Jpn J Cancer Res; 1985 Mar; 76(3):192-6. PubMed ID: 3922837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC; Murphy WM; Daniel DS
    J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat.
    Gottfried-Anacker J; Preussmann R; Eisenbrand G; Janzowski C
    Carcinogenesis; 1985 Nov; 6(11):1559-64. PubMed ID: 4053275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
    Okada M; Suzuki E; Hashimoto Y
    Gan; 1976 Dec; 67(6):825-34. PubMed ID: 191321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary metabolites of N-nitrosodibutylamine and N-nitrodibutylamine in the rat: identification of N-acetyl-S-alkyl-L-cysteines.
    Suzuki E; Osabe M; Okada M; Ishizaka T; Suzuki T
    Jpn J Cancer Res; 1987 Apr; 78(4):382-5. PubMed ID: 3108218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
    Miyakawa M; Yoshida O
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of butylated hydroxyanisole added in vitro or administered to rats on N,N-dibutylnitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine metabolism by post-mitochondrial supernatant of liver homogenates.
    Pastorelli R; Ancidei A; Benfenati E; Fanelli R; Airoldi L
    Toxicology; 1988 Jan; 48(1):71-80. PubMed ID: 3336884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53+/- knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Mori Y; Koide A; Fuwa K; Wanibuchi H; Fukushima S
    Mutagenesis; 2001 Sep; 16(5):377-83. PubMed ID: 11507236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Okajima E; Hiramatsu T; Okamoto M; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Kubota K; Samma S; Okamura K; Kaneko Y; Horii Y; Moriya A
    Gan To Kagaku Ryoho; 1982 May; 9(5):836-42. PubMed ID: 7184430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring endogenous nitrosamine formation in man.
    Ohshima H; Bartsch H
    IARC Sci Publ; 1984; (59):233-46. PubMed ID: 6545281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.